Esthesioneuroblastoma (ENB) is a rare malignant tumour thought to derive from neuroendocrine cells of the olfactory epithelium on the basis of location, morphologic, immunophenotypic and ultrastructural features. In fact, well differentiated ENB is characterized by the presence of neuropil, Homer Wright and olfactory rosettes (Hyams et al, 1988), by a positive immunoreactivity for neuron-specific enolase, synaptophysin, chromogranin and neurofilaments and, ultrastructurally, by cytoplasmic processes, microtubules and dense core granules, all features consistent with an origin in the olfactory epithelium (Shanmugaratnam, 1991; Banerjee et al, 1992) .
was carried out in three cases in order to verify the integrity of the EWS gene.
None of the three different molecular approaches disclosed the presence of any fusion transcripts or EWS rearrangements, neither did immunohistochemistry detect any MIC2 positivity.
MATERIALS AND METHODS

Patients and tumours
The main clinico-pathologic features of the five patients under analysis are summarized in Table 1 . Categorization and grading were performed according to the World Health Organization (WHO) classification (Shanmugaratnam, 1991) , and pre-therapy staging according to the Kadish (1976) system. Case 1 showed typical differentiated 'neuroblastoma like' growth pattern represented by nests of small round cells with reticular areas formed by tangles of neurites emanating from tumour cells. Areas with superimposable features were present in case II which in addition presented solid nests made up of larger tumour cells. The remaining three cases (III, V) were mainly made-up of well-defined cellular nests or lobules of variable size of cells with moderate pale eosinophilic cytoplasm with indistinct membranes surrounded by fibrovascular septae. In particular, a moderate amount of fibrillary background was present in case III and areas forming interconnecting lobules of tumour cells in case V.
All cases with fibrillary stroma (cases I, II, III) showed rosettes, whereas true olfactory (Flexner-Wintersteiner Wright) rosettes were present only in case IV.
Immunocytochemistry
Immunophenotyping was carried out on formalin-fixed, paraffinembedded material in all cases and in appropiate positive and negative controls using antibodies to the following antigens: neuron-specific enolase (NSE) (MIG-N3, Sanbio, 1:400 diluted), chromogranin (CRA237, Cambridge, 1:8000 diluted), synaptophysin (AO10, Dako, 1:100 diluted), S-100 protein (polyclonal, Dako, 1:4000 diluted), and cytocheratin and neurofilament (NF) cocktails as well as p30/32MIC2 (HBA71, 0.13, Labometric, 1/100 diluted; and CD99, Signet, 1:100 diluted). The applied cytocheratin (35β H11 Dako, and CAM 5.2 Becton-Dickinson, 1:100 and 1:20 diluted respectively) and neurofilament (RPN 1103, Amersham, and RPN 1104, Amersham, 1:33 and 1:50 diluted respectively) cocktails provided qualitative demonstration of human cytocheratin numbers 8 and 18, and neurofilament kDa 200 and 160 respectively. Antibody reactivity was visualized using the biotin-streptavidin method (Wood et al, 1981) . For synaptophysin and cytocheratin antibodies, trypsin treatment of the sections was carried out. For NSE, chromogranin, NF antibodies and both HBA71 and CD99, heating-based antigen retrieval (Cattoretti et al, 1992) prior to the application of the primary antibody was applied.
Neuroendocrine markers and structural antigen immunophenotyping was consistent with the ENB diagnosis in all five cases (Table 1) (Frierson, 1990; Shanmugaratnam, 1991) . Diffuse positivity for NSE and strong reactivity for chromogranin and/or synpatophysin was present in all five cases. Immunodecoration for S-100 protein and NFs was restricted to dendritic-subtentacular cells in five cases and neurophil formations in one. One case revealed focal staining for cytokeratins.
Cytogenetic analysis
Metaphases obtained after the short-term (10 days) culture of case III were G-banded, and the karyotype of nine metaphases was determined.
FISH on metaphases
Whole chromosome 22 painting (Cambio, Cambridge, UK) was hybridized, according to Pinkel et al (1986) , on the metaphases from case III in order to confirm the cytogenetic results.
FISH on interphase nuclei
Probes F7 cosmid probes, located distal to the 22 chromosome breakpoint, and 1p3, which proximally flanks and overlaps half the breakpoint on chromosome 11 Zucman et al, 1992) , were labelled by nick translation. Biotin-11-dUTP (Boehringer Mannheim, Germany) was incorporated in F7, and digoxigenin-11-dUTP (Boehringer Mannheim, Germany) in 1p3; 50 ng of both probes were then annealed to 5 µg of unlabelled human competitor DNA to suppress the repetitive sequences, and to 5 µg of carrier salmon sperm DNA. Botinylated chromosome 8 2-satellite (Oncor, Gaithersburg, MD, USA) was used for the detection of chromosome 8 trisomy according to the manufacturer's recommendations. FISH FISH was performed as previously described by Lichter and collaborators (1990) on cases I, III and IV. Independent experiments with a chromosome 8 centromeric probe and with F7 and 1p3 cosmid probes were performed respectively. The hybridization signals of chromosome 8 2-satellite were detected by two layers of avidin-FITC (Vector, Burlingame, CA, USA). The signals of the F7 and 1p3 cosmids were simultaneously detected by two layers of avidin-FITC (which bound to the biotinylated F7 probe) and one layer of rhodamine-labelled anti-digoxigenin (Ab) followed by rabbit anti-sheep (Ab), and finally by rhodamine-labelled anti-rabbit (Ab) (Oncor, Gaithersburg, MD, USA) which bound to the digoxigenin of the 1p3 probe. Slides were then counterstained by DAPI (4,6,-diamidino-2-phenylindole dihydrochloride hydrate).
Digital signal detection
Image acquisition was performed with a cooled CCD camera (Photometrics, Tucson, AZ, USA) coupled with a Zeiss fluorescence microscope and controlled by a Power Macintosh 7100/80. Frames of the nuclei were taken separately using the IPLab Spectrum (Signal Analytics) software package, and pseudocoloured and merged using the Gene Join software (Ried et al, 1992) .
RT-PCR
A frozen tumour fragment from all cases as well as from two Ewing's tumours (ETs) with the EWS/FLI-1 and EWS/ERG fusion transcripts, respectively, representing positive controls, was mechanically disaggregated and total RNA was isolated using the RNAzolB extraction system (TEL-TEST, TX, USA). No positive control was available for the EWS/FEV fusion gene. RNA was also extracted from a normal mesenchymal tissue to be used as negative control. One microgram of total RNA was reverse-transcribed into cDNA using oligo(dT) primers and reverse transcriptase (Superscript, Gibco-BRL) according to the manufacturer's recommendations.
Control amplification of cDNAs was accomplished by using β-actin specific primers (Adams, 1995) and wild-type EWS primers. The detection of the putative EWS/FLI-1, EWS/ERG junction regions was carried out using primers 11.11 and 22.8 (Zucman et al, 1993) and Erg11 ) and 22.8 respectively. The PCR reaction consisted of denaturation at 94°C for 30 s, annealing at 68°C for 1 min and elongation at 72°C for 1 min. Thirty-five cycles were performed. The detection of the putative EWS/FEV was carried out using primers EWS22.14 and Fev 11 at the following PCR conditions: 35 cycles consisting of denaturation at 94°C for 30 s, annealing at 65°C for 1 min and elongation at 72°C for 1 min (Peter et al, 1997) . The amplification products were analysed on 2% TBE1X-agarose gel.
Southern blot
DNA was extracted from cases I, II and IV, as well as from two positive controls containing the EWS/FLI-1 transcript, using the Genomix extraction kit (Talent, Trieste, Italy). Ten micrograms of genomic DNA were digested with EcoRI, Hin dIII, BamHI, SacI and Xhol. Restriction fragments were separated by electrophoresis in 0.8% agarose gel O.N. and transferred to nylon membranes (Hybond-N+; Amersham) by standard methods. Filters were hybridized overnight with a ( 32 P) radiolabelled probe to a high specific activity by random priming (Prime-it Random Primer Labeling Kit, Stratagene). The EWS probe used was a 593 base pair partial cDNA probe generated by standard PCR. This probe corresponds to nucleotides 720-1313 of the EWS cDNA and includes exons 7-12, which constitute the genomic EWS breakpoint cluster region in pPNETs-ETs . The hybridized filters were washed at high stringency and exposed for 2-7 days. Placental DNA was used as normal control and DNAs from two cases with EWS/FLI-I rearrangements were included as positive controls. Figure 2 RT-PCR results. MW: the molecular weight marker is 1 kb. EWS/FLI-1: samples 1-5 were tumour cDNA from cases I-V, sample 6 was tumour cDNA used as positive control for EWS/FLI-1 fusion transcript (500 bp), sample 7 was cDNA from normal tissue used as negative control, and sample 8 was the reaction mixture without cDNA; all were amplified by the EWS/FLI-1 primers 11.11 and 22.8. EWS/ERG: samples 1-8 are the same samples, except for the positive control that contains cDNA from EWS/ERG fusion transcript (490 bp), amplified by the EWS/ERG primers ERG11 and 22.8 EWS/FEV: samples 1-5 were tumour cDNA from cases I-V, sample 6 was the negative control and sample 7 was the reaction mixture without cDNA
RESULTS
By immunohistochemistry the five ENB cases were negative both with the monoclonal antibody HBA71 and CD99 specific for the protein products of the MIC2 gene. The cytogenetic analysis of case III resulted in a normal karyotype, and did not reveal numerical and/or structural chromosome abnormalities or the reciprocal t(11;22)(q24;q12), t(21;22)(q22;q12), t(7;22)(p22;q12), t(17;22)(q12;q12) and the t(2;22)(q33;q12) translocations (Rao et al, 1987; Sorensen et al, 1994; Jeon et al, 1995; Kaneko et al, 1996; Peter et al, 1997) , or trisomy 8. These results were confirmed by a FISH experiment on metaphase spreads by using a chromosome 22 painting probe which detected two normal chromosome 22 (data not shown).
One hundred interphase nuclei were scored for each case with dual colour FISH using the F7 and 1p3 cosmids flanking the EWS/FLI-1 fusion gene. The absence of t(11;22)(q24;q12) was confirmed in all the three patients analysed: the four signals, two green signals corresponding to F7 probe and two red signals corresponding to 1p3 probe were found apart (Figure 1 A, B) . The same experiment performed on a series of Ewing's tumours with a t(11;22), used as positive contol, showed a green/red double spot corresponding to the fusion gene (data not shown).
FISH experiments using a centromeric probe excluded trisomy 8 in cases I and IV, while two different clones were found in case III: one containing three copies of chromosome 8 and the other four (Figure 1 C, D) .
RT-PCR analysis using EWS/FLI-1, EWS/ERG and EWS/FEV primers did not detect fusion transcripts in any of the five ENB cases (Figure 2 ), whereas the positive controls for the first two tranlocations showed the expected specific transcripts. No positive control was available for the EWS/FEV fusion. All the samples showed the expected products when amplified by β-actin specific primers and wild-type EWS primers (Figure 3) .
By Southern blot none of the three cases analysed showed any EWS rearrangement after digestion with EcoR1, Hin dIII, SacI and XhoI enzymes, while the two positive controls carrying a t(11;22) and t(21;22) showed a rearranged fragment of 19 and 21 kb and 20 kb respectively, after digestion with SacI and XhoI enzymes respectively (Figure 4) .
DISCUSSION
Esthesioneuroblastoma is a malignant tumour characterized by variable histology and conflicting immmunophenotyping, cytogenetic and molecular data. Some authors assert the belonging of ENB to the pPNETs-ETs group of tumours through cytogenetic (WhangPeng et al, 1987; Cavazzana et al, 1988; VanDevanter et al, 1991) or molecular evidence (Sorensen et al, 1996) , whereas others disagree because of opposite immunophenotypic (Nelson et al, 1995) and/or molecular results (Mezzelani et al, 1997; Argani et al, 1998) .
In order to address this issue we analysed five consecutive cases of ENB tumour specimens using both cytogenetic and molecular techniques. All cases were consistent with olfactory neuroblastoma in terms of morphology and tumour-specific immunophenotype, as well as development site and clinical presentation. As for MIC2 gene expression, all our cases showed null MIC2 gene immunophenotype, in agreement with the recent report of Nelson et al (1995) . Furthermore, the results we obtained on the original uncultured tumour specimens by dual colour FISH in cases I, III and IV, RT-PCR in all cases, and by Southern blot in cases I, II and IV all confirmed the absence of any EWS rearrangements. In fact we did not find any evidence of EWS/FLI-1 fusion gene by FISH on interphase nuclei, or of EWS/FLI-1 fusion transcripts, or of EWS/ERG and EWS/FEV variants by cDNA amplification. The same was true for Southern blot analysis that confirmed the EWS gene integrity. Case III was the only tumour whose cells were successfully cultured in vitro short-term culture. The culture was harvested after 10 days, and the metaphases showed a normal 46,XY karyotype. Since it has been reported that during the in vitro culture fibroblasts could overgrow tumour cells (Jin et al, 1995) , we must take this potential bias into account.
We attribute the robustness of our approach to three factors. First, the reliability of the RT-PCR results are based on the fact that the cDNA adequacy was tested by both β-actin and EWS amplification as well as on the amplification of positive controls. Second, even though in theory, rearrangements of the EWS locus could be excluded only by complete sequencing of the tumour DNA, we undertook an extended Southern blot analysis. In our experience, pPNETs-ETs DNA carrying EWS/FLI-1 transcript does not always show EWS rearrangement when digested by EcoR1 and HindIII enzymes. In fact, only the use of rare cuttering enzymes, such as SacI and XhoI, allowed us to demonstrate the presence of EWS rearrangements in these samples and thus to ultimately exclude the presence of rearrangements in our ENB cases. Third, FISH allowed a cell by cell analysis that excluded the presence of the EWS/FLI-1 transcript in the three tested ENB and, by contrast, showed it in a series of pPNETs-ETs.
The presence, in Case III, of two different clones containing three and four copies of chromosome 8, respectively, is not sufficiently understood. Although, trisomy 8 is described as the most common secondary anomaly in neuroectodermal tumours , it is also a frequent abnormality in different tumour types. In fact, trisomy 8 is a non-random secondary change in other soft tissue tumours, such as clear cell sarcoma (Travis et al, 1992) and myxoid liposarcoma (Sreekantaiah et al, 1994) and appears as the only chromosome abnormality in several myeloid and lymphoid disorders (Mitelman, 1985; Haim and Mitelman, 1995) along with superficial and deep fibromatosis (Somers et al, 1987; Dal Cin et al, 1994) .
In conclusion, on the basis of our data and a critical analysis of the literature, we are inclined to assert that ENB may represent a distinct entity as opposed to being a member of the pPNETs-ETs. In fact, only four out of 27 ENB cases (Wang-Peng et al, 1987; Cavazzana et al, 1988; Sorensen et al, 1996) cytogenetically or molecularly analysed, showed the EWS/FLI-1 fusion gene. As already argued (Nelson et al, 1995) two of the three ENB cell lines described to carry the t(11;22)(q24;q12)-derived EWS/FLI-1 fusion transcript (Whang-Peng et al, 1987; Cavazzana et al, 1988; Sorensen et al, 1996) probably represent metastatic lesions deriving from a primary pPNET-ET in the chest wall and in the paraspinal region, respectively, and metastasizing to the nasal cavity. Two additional primary ENBs described by Sorensen et al (1996) could represent pPNETS-ETs or extraskeletal ETs arising in the nasal fossa, as previously described by Pontius and Sebek (1982) , and Lane and Ironside (1990) . The remaining three cases with abnormal karyotype described by other authors did not show a t(11;22) translocation (Castaneda et al, 1991; Van Devanter et al, 1991; Jin et al, 1995) . Finally, the immunophenotypic data from 43 cases were all consistent with a lack of MIC2 protein product (Nelson et al, 1995; Argani et al, 1998) .
